显微镜与内镜经蝶窦垂体手术相关并发症:单中心三级垂体中心1153例连续病例经验
该研究回顾性分析1992年11月至2017年3月USC Keck医院1153例连续经蝶窦垂体腺瘤切除术,显微镜组占85.3%、内镜组占14.7%。围手术期死亡1例(0.1%),死亡或重度残疾率为0.26%;内镜与显微镜入路手术并发症(6.4% vs 8.8%,p=0.247)及内分泌并发症(11.4% vs 11.8%,p=0.888)无显著差异。既往经蝶手术、术前视力丧失及MRI示垂体腺瘤侵袭是手术并发症的危险因素。
要点
- 总体围手术期死亡1例(0.1%),死亡或重度残疾率为0.26%。
- 内镜与显微镜入路手术并发症(6.4% vs 8.8%,p=0.247)及内分泌并发症(11.4% vs 11.8%,p=0.888)无显著差异。
- 既往经蝶手术(11.4% vs 6.8%,p=0.025)、术前视力丧失(10.3% vs 6.8%,p=0.002)、MRI示肿瘤侵袭(8.5% vs 4.4%,p=0.007)为手术并发症危险因素。
核心结论
- 在该单中心三级中心研究中,经蝶窦垂体腺瘤切除术的死亡或重度残疾率为0.26%。
- 并发症危险因素包括既往手术治疗和垂体腺瘤侵袭。
- 内镜与显微镜手术并发症发生率无差异。
- 作者认为,在经验丰富的垂体中心施行经蝶窦垂体腺瘤手术可能具有高度安全性。
研究设计与样本
- 回顾性分析1992年11月至2017年3月在USC Keck医院施行的1153例连续经蝶窦垂体腺瘤切除术。
- 显微镜经蝶窦切除术占85.3%,内镜经蝶窦切除术占14.7%。
- 分析围手术期并发症及患者和肿瘤危险因素。
主要发现
- 总体中位住院时间为3天,围手术期死亡1例(0.1%)。
- 手术并发症包括术后脑脊液漏(2.6%)、鼻出血(1.1%)、术后血肿(1.1%)、脑膜炎(1.0%)、脑神经麻痹(0.8%)、脑积水(0.8%)、视力丧失(0.6%)、卒中(0.3%)、腹部血肿或感染(0.2%)、颈动脉损伤(0.1%)和植物状态(0.2%)。
- 围手术期内科并发症包括菌血症/脓毒症(0.5%)、肺炎(0.3%)、心肌梗死(0.3%)和深静脉血栓/肺栓塞(0.1%)。
- 内分泌并发症最常见,包括一过性尿崩症(4.3%)、症状性低钠血症(4.2%)、新发垂体功能减退(任何轴)(3.6%)、永久性尿崩症(0.3%)和肾上腺功能不全(0.2%)。
- 内镜与显微镜入路手术并发症(6.4% vs 8.8%,p=0.247)及内分泌并发症(11.4% vs 11.8%,p=0.888)无显著差异。
临床怎么用
- 作者认为,在经验丰富的垂体中心施行经蝶窦垂体腺瘤手术可能具有高度安全性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pituitary adenomas (PAs) are benign neoplasms that are frequently encountered during workup for endocrinopathy, headache, or visual loss. Transsphenoidal surgery remains the first-line approach for PA resection. The authors retrospectively assessed complication rates associated with transsphenoidal PA resection from an institutional database. METHODS: A retrospective analysis of 1153 consecutive transsphenoidal pituitary adenoma resections performed at the Keck Hospital of USC between November 1992 and March 2017 was conducted. Microscopic transsphenoidal resection was performed in 85.3% of cases, and endoscopic transsphenoidal resection was performed in 14.7%. Analysis of perioperative complications and patient and tumor risk factors was conducted. RESULTS: The overall median hospital stay was 3 days. There was 1 perioperative death (0.1%). Surgical complications included postoperative cerebrospinal fluid leak (2.6%), epistaxis (1.1%), postoperative hematoma (1.1%), meningitis (1.0%), cranial nerve paresis (0.8%), hydrocephalus (0.8%), vision loss (0.6%), stroke (0.3%), abdominal hematoma or infection (0.2%), carotid artery injury (0.1%), and vegetative state (0.2%). Perioperative medical complications included bacteremia/sepsis (0.5%), pneumonia (0.3%), myocardial infarction (0.3%), and deep venous thrombosis/pulmonary embolism (0.1%). Endocrine complications were the most frequent, including transient diabetes insipidus (4.3%), symptomatic hyponatremia (4.2%), new hypopituitarism (any axis) (3.6%), permanent diabetes insipidus (0.3%), and adrenal insufficiency (0.2%). There were no significant differences between microscopic and endoscopic approaches with regard to surgical complications (6.4% vs 8.8%, p = 0.247) or endocrine complications (11.4 vs 11.8%, p = 0.888). Risk factors for surgical complications included prior transsphenoidal surgery (11.4% vs 6.8%, p = 0.025), preoperative vision loss (10.3% vs 6.8%, p = 0.002), and presence of PA invasion on MRI (8.5% vs 4.4%, p = 0.007). CONCLUSIONS: In this single tertiary center study assessing complications associated with transsphenoidal PA resection, the rate of death or major disability was 0.26%. Risk factors for complications included prior surgical treatment and PA invasion. No differences in complication rates between endoscopic and microscopic surgery were observed. When performed at experienced pituitary centers, transsphenoidal surgery for PAs may be performed with a high degree of safety.
引用
- Agam MS, Wedemeyer MA, Wrobel B, et al. Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center. J Neurosurg. 2018. PMID: 29999459. doi:10.3171/2017.12.JNS172318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。